The GSTP1-based prognostic model had excellent predictive efficiency.<h4>Discussion</h4>BioA may exert anti-glioma effects by regulating GSTP1, providing theoretical support for its clinical application and a new therapeutic target for glioma. This evidence concerns the gene GSTP1 and central nervous system cancer.